Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Esperion Theraptc Cmn (ESPR)

44.34 +2.03 (+4.80%)

6/23/2017  4:00pm

Open:

43.17

Pre. Close:

42.31

High:

44.54

Low:

41.42

Volume:

1,174,636

Market Cap:

1.00B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

45.15 - 46.17

46.17 - 46.71

Low:

40.07 - 40.67

40.67 - 40.98

Close:

43.63 - 44.87

44.87 - 45.52

Technical analysis  (as of: 2017-06-23 4:34:14 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 52.02     One year: 60.76

Support:

Support1: 36.14    Support2: 30.95

Resistance:

Resistance1: 44.54    Resistance2: 52.02

Pivot:

36.31

Moving Averages:

MA(5): 39.30     MA(20): 35.38

MA(100): 32.17     MA(250): 19.92

MACD:

MACD(12,26): 1.47     Signal(12,26,9): 0.40

%K %D:

%K(14,3): 93.61     %D(3): 79.59

RSI:

RSI(14): 75.34

52-Week:

High: 48.21  Low: 9.40  Change(%): 162.4

Average Vol(K):

3-Month: 55138  10-Days 769

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ESPR has closed above the upper band by 10.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 42.2% wider than normal. The large width of the bands suggest high volatility as compared to ESPR's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Mon, 20 Mar 2017 15:01:18 GMT
Esperion Therapeutics stock surges 52% after it says the FDA gave its drug ...

Fri, 03 Feb 2017 20:38:29 GMT
Why Esperion Therapeutics, Inc. Is Soaring Today

Thu, 22 Jun 2017 19:41:15 GMT
Just the Facts on Esperion Therapeutics, Inc. (ESPR)

Thu, 22 Jun 2017 20:02:23 GMT
Esperion Therapeutics Inc (ESPR) Needle Moving on Volume

Wed, 31 May 2017 16:30:00 GMT
Commit To Purchase Esperion Therapeutics At $27, Earn 21.2% Annualized Using ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

22.59

Shares Float (M)

13.63

% Held by Insiders

31.62

% Held by Institutions

76.40

Shares Short (K)

4140

Shares Short Prior Month (K)

4490

Stock Financials

EPS

-4.480

EPS Est. Current Year

-6.690

EPS Est. Next Year

-4.360

EPS Est. Next Quarter

-1.650

Forward EPS

-4.362

Book Value (p.s.)

8.520

PEG Ratio

0.85

Profit Margin

Operating Margin

Return on Assets (ttm)

-25.5

Return on Equity (ttm)

-42.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-4.514

Qtrly Earnings Growth

Operating Cash Flow (M)

-72.24

Levered Free Cash Flow (M)

-36.40

FoxReading.com

Valuation

P/E

-9.90

P/E Growth Ratio

0.05

P/BV

5.20

P/S

P/CF

-13.87

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.